Immix Biopharma Inc
NASDAQ:IMMX

Watchlist Manager
Immix Biopharma Inc Logo
Immix Biopharma Inc
NASDAQ:IMMX
Watchlist
Price: 6.73 USD 1.97% Market Closed
Market Cap: 226m USD

Relative Value

There is not enough data to reliably calculate the relative value of IMMX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMMX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.9
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-2.9
Industry
24
Forward
-8.2
vs History
vs Industry
Median 3Y
-4.3
Median 5Y
-4.9
Industry
21.6
vs History
vs Industry
Median 3Y
-4.2
Median 5Y
-4.5
Industry
23.7
vs History
0
vs Industry
32
Median 3Y
3.3
Median 5Y
2.8
Industry
3.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.3
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.2
Industry
6.7
Forward
-7.8
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.2
Industry
7.2
Forward
-7.7
vs History
vs Industry
Median 3Y
-2.8
Median 5Y
-2.9
Industry
8.2
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.8
Industry
6.7
vs History
vs Industry
15
Median 3Y
13.2
Median 5Y
10.7
Industry
5.7

Multiples Across Competitors

IMMX Competitors Multiples
Immix Biopharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Immix Biopharma Inc
NASDAQ:IMMX
222.3m USD 0 -9.4 -8.6 -8.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 924 975 -161 240.4 -195 797.2 -193 563
US
Abbvie Inc
NYSE:ABBV
398B USD 6.7 169.5 16.4 23.3
US
Amgen Inc
NASDAQ:AMGN
170.3B USD 4.7 24.2 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
150.7B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.4B USD 9.5 30.7 22.2 23.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 076.6 -529.9 -577 -561.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.5B USD 5.4 16.7 15.6 17.7
AU
CSL Ltd
ASX:CSL
87.9B AUD 3.8 19.5 13.1 16.4
NL
argenx SE
XBRU:ARGX
47B EUR 15.3 35.9 62.1 63.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
54B USD 16.6 1 223.6 163 197.7
P/S Multiple
Revenue Growth P/S to Growth
US
Immix Biopharma Inc
NASDAQ:IMMX
Average P/S: 3 392 711.9
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 924 975
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.7
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
5%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
10%
0.9
US
E
Epizyme Inc
F:EPE
2 076.6
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.4
6%
0.9
AU
CSL Ltd
ASX:CSL
3.8
5%
0.8
NL
argenx SE
XBRU:ARGX
15.3
49%
0.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.6
46%
0.4
P/E Multiple
Earnings Growth PEG
US
Immix Biopharma Inc
NASDAQ:IMMX
Average P/E: 192.3
Negative Multiple: -9.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 240.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.2
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.7
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -529.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.7
9%
1.9
AU
CSL Ltd
ASX:CSL
19.5
11%
1.8
NL
argenx SE
XBRU:ARGX
35.9
40%
0.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 223.6
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Immix Biopharma Inc
NASDAQ:IMMX
Average EV/EBITDA: 40.3
Negative Multiple: -8.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 797.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.4
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.2
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -577 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.6
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
NL
argenx SE
XBRU:ARGX
62.1
807%
0.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
163
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Immix Biopharma Inc
NASDAQ:IMMX
Average EV/EBIT: 46.5
Negative Multiple: -8.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 563 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.3
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.2
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -561.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
13%
1.4
AU
CSL Ltd
ASX:CSL
16.4
11%
1.5
NL
argenx SE
XBRU:ARGX
63.8
N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
197.7
N/A N/A